Lithium-Ion Battery Fire Statistics | Everything You Need to Know

Get the facts on lithium battery fire statistics from our comprehensive overview. If you were injured due to a lithium battery contact us for a free consultation

Read Our Featured Blog
Read the full story
Arrow button
Blog Posts
Check out our
Recent posts
November 1, 2016
Verdict: $70 million Talcum Powder jury verdict in St. Louis Missouri
Johnson and Johnson (J&J) lost another verdict regarding its failure to warn about the potential risk of ovarian cancer from talcum powder products. A St. Louis Missouri jury awarded Deborah Giannecchini $2.5 million from J&J in pain and suffering, another $2.5 million from co-defendant Imerys Talc America, and ordered Johnson and Johnson to pay an additional $65 million in punitive damages.
May 10, 2016
14 year old blinded by exploding e-cigarette
The Kings Plaza Mall in Brooklyn, NY is not allowed to sell devices to those under the age of 21, according to local New York city laws. Despite this, the 14 year old was handed an e-cigarette that the contained a dangerous battery. E-cig batteries like all batteries have physical limits regarding charging or discharging limits, and many e-cigarette’s have universal ports to plug with a variety of chargers. Many e-cig devices contain no safety features to detect if a battery has been charged in an unsafe manner, either internally or externally.
May 3, 2016
$55 Million Verdict in Ovarian Cancer Baby Powder Lawsuit
Jurors found Johnson & Johnson liable for its baby powder product causing ovarian cancer and reached a $55 million verdict against J&J. The lawsuit was brought by Gloria Restesund of Missouri, a woman who had used J&J’s talcum products powder products (Baby Powder, Shower to Shower) for 40 years and who later developed ovarian cancer as a result.
March 22, 2016
Doctors who receive pharma money prescribe more brand drugs
ProPublica studied five different specialties to compare the rates by which doctors who receive money from big pharma prescribe typically more expensive brand name medication, versus doctors who haven’t taken money from pharma. The analysis found that doctors who receive $5,000 or more from pharmaceutical companies in a given year all prescribe more brand name medication.
March 17, 2016
Texas Jury Renders $498 Million DePuy Pinnacle Verdict
DePuy Orthopaedics Inc. and its parent company, Johnson and Johnson (J&J), were found liable by a Texas jury for injuries resulting from its DePuy Pinnacle defective products. DePuy designed and manufactured the DePuy Pinnacle stem and DePuy Ultamet liners, which when used together, form a cobalt and chromium “metal on metal” hip design.
March 2, 2016
Endo to Stop AMS Mesh Production
Endo International PLC disclosed it is officially closing its women’s health division and stopping the manufacture and sale of transvaginal mesh products. Endo disclosed this after release of its quarterly results on Monday, stating that it will close down the mesh line purchased from American Medical Systems (AMS) by March 31, 2016. Endo failed to find a buyer for the product line (now known as Astora Women’s Health).
February 26, 2016
E-Cig Battery Explodes Burning Man’s Leg [VIDEO]
Owensboro, KY: E-Cigarette (E-Cig) devices frequently utilize lithium-ion batteries with basic safety mechanisms. Due to this reports of failures have been occurring at increasing rates. Watch this video of a man’s pants exploding and catching on fire when his e-cig battery explodes
February 24, 2016
Verdict: Johnson & Johnson liable for $72 million in Talcum Powder Ovarian Cancer lawsuit
A jury presiding over the case of a women who died at the age of 62 from ovarian cancer found Johnson & Johnson liable for her death. The jury verdict included $10 million in damages plus an additional $62 million in punitive damages. The jury agreed that Johnson & Johnson, creator of Shower to Shower and Baby Powder products, had hidden the risks of talcum powder and links to ovarian cancer for decades. Ms. Fox had used talc powder products for 35 years.
January 13, 2016
FDA labels Transvaginal Mesh High-Risk
The Federal Drug Administration (FDA) has labeled Pelvic Organ Prolapse (POP) devices as “high risk”, after thousands of injuries had been reported. The FDA noted more than 4,000 reports of adverse events or complications associated with transvaginal surgical mesh for POP or Stress Urinary Incontinence (SUI) repair from 2005 to 2010.
March 4, 2014
Did Studies Sponsored by Pharmaceutical Companies Hide Risks of Testosterone?
An article published in November in BioMed Central discovered serious differences between studies funded by pharmaceutical companies selling testosterone therapy drugs, and those that were independent of pharmaceutical companies pushing the drugs.